contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.​

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

ardenHEADERnew.png

Arden's Day Blog

Arden's Day is a type I diabetes care giver blog written by author Scott Benner. Scott has been a stay-at-home dad since 2000, he is the author of the award winning parenting memoir, 'Life Is Short, Laundry Is Eternal'. Arden's Day is an honest and transparent look at life with diabetes - since 2007.

type I diabetes, parent of type I child, diabetes Blog, OmniPod, DexCom, insulin pump, CGM, continuous glucose monitor, Arden, Arden's Day, Scott Benner, JDRF, diabetes, juvenile diabetes, daddy blog, blog, stay at home parent, DOC, twitter, Facebook, @ardensday, 504 plan, Life Is Short, Laundry Is Eternal, Dexcom SHARE, 生命是短暂的,洗衣是永恒的, Shēngmìng shì duǎnzàn de, xǐyī shì yǒnghéng de

Filtering by Category: Daddy's Blog

Mary Tyler Moore Dead at 80

Scott Benner

Mary Tyler Moore was diagnosed with type 1 diabetes at the age of 33... 

from the Associated Press

NEW YORK (AP) — Mary Tyler Moore, the star of TV's beloved "The Mary Tyler Moore Show" whose comic realism helped revolutionize the depiction of women on the small screen, has died.

Moore died Wednesday with her husband and friends nearby, her publicist, Mara Buxbaum, said. She was 80.

Moore gained fame in the 1960s as the frazzled wife Laura Petrie on "The Dick Van Dyke Show." In the 1970s, she created one of TV's first career-woman sitcom heroines in "The Mary Tyler Moore Show."

She won seven Emmy awards over the years and was nominated for an Oscar for her 1980 portrayal of an affluent mother whose son is accidentally killed in "Ordinary People."

She had battled diabetes for many years. In 2011, she underwent surgery to remove a benign tumor on the lining of her brain.

The entire AP article is here.

Actress Mary Tyler Moore is the international chairman of the Juvenile Diabetes Research Foundation and spoke on raising awareness and funds for Diabetes.


Decision Moves Continuous Glucose Monitors One Step Closer to Medicare Coverage

Scott Benner

great news from JDRF.org !!

January 12, 2017

Continuous glucose monitoring (CGM) devices approved by the FDA for use in making diabetes treatment decisions are durable medical equipment, according to a decision today by the Centers for Medicare & Medicaid Services (CMS). That determination removed a major roadblock to the devices’ coverage under Medicare. Today’s decisions mean that CGMs approved by the FDA for use in making diabetes treatment decisions are eligible for reimbursement under Medicare.

Today’s decision creates a pathway for Medicare coverage for the devices that will bring the nation’s largest insurer in line with the vast majority of the country’s private payers. Although the significant benefits of CGM use have been known since 2008, CMS had previously refused to consider covering the devices under Medicare, saying they did not meet the statutory definitions of durable medical equipment or any other category the agency could cover. Today’s decision removes that impediment.

“JDRF is encouraged by this decision, which will bring us closer to Medicare coverage for continuous glucose monitors,” said Aaron J. Kowalski, PhD, JDRF’s Chief Mission Officer. “I want to thank the tireless JDRF advocates and Congressional champions who have made this progress possible.”

the entire press release can be found here on the JDRF website


Dexcom G5 Mobile Gains Apple Watch Complications!

Scott Benner

Do you know what watch complications are? 

Complications are the newest feature for the Apple Watch app. Dexcom G5 users with an Apple Watch can choose from 4 different watch faces and by just lifting their wrist they can quickly and easily see their glucose level and trend arrow.

Complications are small visual elements on the watch face that communicate important information to the user. The term complication comes from watch making, where the addition of features added complexity to the watch construction. Complications are visible whenever the user looks at the watch face, and users can customize which complications are displayed. The number of slots available for complications on a given watch face varies, but most support at least two or three complications.
— Apple Developer Website

Dexcom representatives told me....

click to expand

"We have seen many social media posts indicating that our users have purchased the Apple Watch primarily because Dexcom CGM glucose data is available on the watch. We are excited that this release will allow our users with an Apple Watch even greater convenience for those who want this important information in an easy-to-use and discreet form."

click to expand

"Close collaboration took place with Apple to get the watch platform to support our use case of 288 updates/day to make this feature possible for CGM. The Dexcom Watch Face was shown at last year’s World Wide Developers Conference in September, and its currently being promoted on Apple’s website in two locations, (1) on great new features of watchOS3, and (2) third-party ecosystems that make the Apple Watch great. Below are screenshots from both of Apple’s website locations."

click to expand

"As part of Dexcom’s commitment of continuous improvement in the quality and user experience of our apps, the 1.6 release also includes several sustaining improvements and enhancements."

Dexcom apps are available for iOS here. 

Click here to learn more about Dexcom

Dexcom G5 App v1.6 and Apple Watch running watchOS 3 or later required. US only.


Novo Nordisk Receives FDA Approval of Tresiba® for Use in Children

Scott Benner

Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes

Tresiba® is the only long-acting insulin approved for use in people with type 1 and type 2 diabetes as young as age one

from PRNewswire

PLAINSBORO, N.J., Dec. 19, 2016 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL), a once-daily, long-acting basal insulin, to be used in children and adolescents with diabetes. Tresiba®, first approved by the FDA in September 2015, is now indicated to improve glycemic control in patients with type 1 and type 2 diabetes from the age of one through adulthood,1making it the only basal insulin approved for both type 1 and type 2 diabetes in patients as young as 1 year old. Tresiba® is a long-acting insulin that is released over time, has a 25 hour half-life and has a consistently flat and stable profile at steady state.1

"We are seeing a rise in the number of children and adolescents with diabetes in the U.S., especially those with type 2, and are proud to support these patients by offering new and effective treatment options," said Todd Hobbs, M.D., U.S. chief medical officer, Novo Nordisk.2 "It can be challenging for children with type 1 diabetes and their parents to manage blood sugar levels and keep up with multiple injections throughout an already busy day. With this approval, they now have another option of a long-acting insulin that is dosed once daily."

Novo Nordisk submitted the supplemental New Drug Application (sNDA) based on the results of the BEGIN™ Young 1 trial, a multi-national, 26-week, phase 3b, randomized, controlled, open-label, parallel-group, treat-to-target non-inferiority trial with a 26-week extension. BEGIN™ Young 1 compared the efficacy and safety of Tresiba® administered once-daily compared with Levemir® (insulin detemir [rDNA origin] injection) administered once-daily or twice daily, both in combination with insulin aspart, a mealtime insulin, in children and adolescents with type 1 diabetes aged 1 to 17. The results showed that Tresiba® in combination with insulin aspart effectively improved glycemic control. The most common adverse events were infection, hypoglycemia and hyperglycemia.3 The use of Tresiba® in patients one year of age and older with type 2 diabetes mellitus is also supported by evidence from adequate and well-controlled studies in adults with type 2 diabetes.1

Once-daily Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) is available in Novo Nordisk's latest insulin delivery device – FlexTouch® – as a 100 units/mL or 200 units/mL pen. Tresiba® U-100 FlexTouch® can deliver up to 80 units of insulin in a single injection. Tresiba® U-200 FlexTouch® can dose up to 160 units in a single injection. FlexTouch® is also the only prefilled insulin pen with no push-button extension.1

Eligible patients with commercial insurance can use the Tresiba® Instant Savings Card to reduce co-pays to as low as $15 a month for up to 24 months. Eligibility and other restrictions apply. For complete terms and conditions and any questions regarding eligibility, visit https://www.tresiba.com/instant-savings-card/eligibility.html or call 1-855-834-3466.


Bold is my Favorite Word

Scott Benner

A long time ago on a Diabetes Facebook page that now seems far away...

The sky was always falling... Real conniptions were omnipresent... Shit was bananas... You name the panic, it was at the disco. We were ALL GOING TO DIE, like right now.

I am very happy to report that the sky is not falling and that we are all going to be fine. However, there was a time when you wouldn't have known that if you were a person looking for support (in some corners of the diabetes community), but that time seems to be changing more with each passing day. I couldn't be any more pleased to see it go or any happier to learn of what has replaced it. Maybe I should explain.

Living with diabetes requires support and finding that support online can actually be a huge and extremely helpful part of moving forward. There can however, be a downside; for example... What happens when you "arrive" online two days after the person that you are suddenly taking advice from? To you this well-meaning person seems sage like and you are apt to take their words as law. What happens when your new found guru is scared (as most rightfully are in the beginning) and at a loss for what to do next? Well, when they are afraid your understanding quickly aligns with theirs as it enforces your fear and uncertainty. That fear often imprints on you and all of your expectations and experiences going forward become tinted in that light. Now maybe you'll get lucky and log on while someone who is a little farther along the path is online and offering answers. In that situation the positive attitude and learnid experience that follow will lead you in a more positive direction. But what happens when twenty people offer their opinions in a thread and they all seem to be different - usually our minds will find truth in the feelings that we are currently experiencing. Basically, if the new person is scared, they follow the fear based answers and vice-versa. These initial interactions are, in my opinion, of vital importance especially early after diagnosis.

Many years ago I made it my personal goal to try and affect that part of our community. I thought that if enough newly diagnosed people felt empowered, understood insulin and began seeing positive outcomes sooner than expected, when it was their turn to give back to the community they'd begin from that position. I believe that when you have a bit of information, support, perspective and a reasonable yet positive expectation; you are well on your way down the path that leads to a healthier and happier life with diabetes.

Basically Instead of...

Q. I'm seeing mealtime spikes, what can I do?

A. Too bad sister, that's diabetes. You're screwed.

I was hoping for...

Q. I'm seeing mealtime spikes, what can I do?

A. Have you tried to pre-bolus? Tell me more about the starting BG when you ate. Don't worry this is easily fixed by understanding how insulin works - you're going to be fine!

I wanted to change the perception that all is lost and there is no way out because I don't believe that and it is simply not true. In my experience the sooner you have a meaningful direction supported by actionable facts, that sooner things will be okay again.

So I began to write blogs about ignoring fear, I talked more openly about how we manage, how insulin works and taking more control in endo appointments and while your children are sleeping and in school. I wanted people to have a chance to begin at the end. I thought this was possible because (do you want to hear a secret?)... largely confidence is one part preparedness and one part pollyanna. All you really need to begin to live well with type 1 is the facts and someone to stand on the other side of the room cheering for you with blinding encouragement. Recently I've begun to notice that those private Facebook groups that I spoke about are trending toward "yes you can and here's how" and getting away from, "dig a hole and climb in - you're cooked". There has even been a severe reduction in the posts that are designed to draw in people who are struggling so everyone can commiserate in a way that allows for them to give up. When giving up feels (and has been assured by others) like the only path left, struggles will follow. There is nothing wrong with a good cry once and a while but after that, back up, keep going, find a better answer than the one you currently have and put it into practice.

Of all of the things that I've tried I am particularly proud of a few Juicebox Podcast episodes that I see people talking about online. Every time that I see someone saying that they are being 'bold with insulin', my heart warms in ways that you can't imagine. 

So thank you if you've been part of ignoring the fear and being bold and for sharing your strength instead of your anxiety, you are shaping a community that will help to form a new generation of what people living with diabetes expect from their lives. Happy Diabetes Awareness Month!

Listen to the Juicebox Podcast on: itunes/ios - google play/android - iheart radio -  or your favorite podcast app. subscribe today!